Airway inflammation and fear: neuroimmune mechanisms and forebrain circuits
气道炎症和恐惧:神经免疫机制和前脑回路
基本信息
- 批准号:10668648
- 负责人:
- 金额:$ 35.09万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-08-08 至 2024-07-31
- 项目状态:已结题
- 来源:
- 关键词:AreaAsthmaAttenuatedAutoimmune DiseasesBehaviorBiological Response ModifiersBrainCellsChronicComplexDataDiseaseEndothelial CellsEnsureExtinction (Psychology)Extrinsic asthmaFemaleFreezingFrightFunctional disorderGene Expression ProfileGeneticHouse Dust Mite AllergensImmuneImmune TargetingImmune responseImmunoglobulin GImpairmentInbred BALB C MiceIndividualInflammationInflammation MediatorsInflammatoryInterleukin-17LinkMeasuresMediatingMediator of activation proteinMental HealthMental disordersMeta-AnalysisModelingMusNatureNeurogliaNeuroimmuneNeuroimmunomodulationNeuronsOrganPathologyPeripheralPost-Traumatic Stress DisordersPredispositionPrefrontal CortexPrevalenceProsencephalonPublishingPulmonary InflammationPyroglyphidaeReceptor SignalingRecombinantsRecording of previous eventsRegulationReportingRiskRisk FactorsRoleSafetySignal PathwaySignal TransductionStainsSubfornical OrganT-LymphocyteTestingTissuesTranscription AlterationTraumaValidationVirusairborne allergenairway inflammationantagonistcombat veterancomorbiditydesigner receptors exclusively activated by designer drugsdisorder riskinhibitory neuronmalemouse modelneutralizing antibodyneutralizing monoclonal antibodiesnew therapeutic targetnovelnovel therapeuticsoutcome predictionreceptorresponsesingle-cell RNA sequencingsmall molecule inhibitorsymptom treatmentsystemic inflammatory responsetherapeutic targettherapy resistanttranscriptomicstrauma exposure
项目摘要
PROJECT SUMMARY:
Effective regulation of fear is essential for optimal mental health. Fear dysregulation is a hallmark of post-
traumatic stress disorder (PTSD), a debilitating condition afflicting 22% of combat veterans. Impaired prefrontal
cortex (PFC) functioning contributes to fear dysregulation in PTSD. Not all trauma-exposed individuals develop
PTSD suggesting pre-trauma risk factors. Elucidating the nature of such factors will help identify novel
therapeutics. Recent evidence supports an association between chronic inflammation and PTSD risk.
Accordingly, many inflammatory diseases are linked to increased PTSD. Growing evidence supports a strong
association between severe asthma and PTSD, however the severe asthma associated factors and mechanisms
that regulate PTSD relevant PFC deficits remain unknown. Our published and recent data using unique mouse
paradigms of aeroallergen house dust mite (HDM)-induced driven inflammation, show compromised fear
extinction only in mice with Th17/IL17A expansion, an effect dependent on IL17A receptor signaling and
peripheral IL17A. Importantly, this is accompanied by 1) reduced neuronal activation in the PFC an extinction-
regulatory area and 2) microglial/T cell/endothelial alterations within the subfornical organ (SFO), a BBB-devoid
area projecting to the PFC. Collectively these observations inform our hypothesis: severe asthma relevant IL-
17A activates a complex, multi-cellular signaling cascade within the SFO which engages the PFC to regulate
fear. This hypothesis will be tested in 3 aims. Aim 1 will determine if IL-17A signaling, and Th17 cell activity
is necessary and sufficient for HDM-Th17/IL17A driven fear extinction deficits The ability of IL-17A
blockade (neutralizing mAb) or Th17 antagonism (small molecule inhibitor) to reverse fear extinction
deficits/neuroimmune alterations in mice with Th2/Th17 responses, or recombinant IL17A to induce fear
extinction deficits/neuroimmune alterations in mice with Th2 responses will be assessed. Aim 2 will determine
if SFO?IL projections are necessary and sufficient for HDM-Th17/IL17A driven fear extinction deficits
Using a retroCre-dependent chemogenetic strategy we will inhibit or activate SFO?IL projections to assess
effects on fear extinction in HDM treated mice with Th2 versus Th2/Th17A Aim 3 will identify transcriptomic
profiles in the SFO and PFC associated with HDM-Th2/Th17 effects and fear Using single-cell RNAseq, the
transcriptional profile of SFO and PFC derived cells will be generated with cell-specific signatures of immune
cells, glia, endothelial cells and neurons to identify DEGs and signaling pathways uniquely activated in HDM
TH2 vs Th2/Th17 mice. Validation and association with HDM-Th2/Th17 effects on fear will be performed using
Aim 1/Aim 2 tissue. Impact: Our data reveals a unique core mechanism by which adaptive immune mediators
associated with chronic lung inflammation regulate cortical deficits and fear, relevant to mental health.
Completion of these studies will broaden our understanding of how peripheral inflammatory mediators modulate
brain function and behavior and identify novel risk factors and therapeutic targets for fear-associated pathologies.
项目摘要:
有效的恐惧调节对于最佳心理健康至关重要。担心失调是后期的标志 -
创伤性应激障碍(PTSD),这是一种使战斗退伍军人的衰弱的疾病。前额叶受损
皮层(PFC)的功能导致PTSD中的恐惧失调。并非所有暴露于创伤的人都会发展
PTSD提出了创伤前风险因素。阐明此类因素的性质将有助于识别新颖
疗法。最近的证据支持慢性炎症与PTSD风险之间的关联。
因此,许多炎症性疾病与PTSD增加有关。越来越多的证据支持一个强大的
严重的哮喘和PTSD之间的关联,但是严重的哮喘相关因素和机制
调节PTSD相关的PFC缺陷仍然未知。我们使用唯一鼠标发布的发布和最新数据
Aeroallergen House House Dust Mite(HDM)引起的驱动炎症的范例,表现出受损的恐惧
仅在具有TH17/IL17A膨胀的小鼠中灭绝,效果取决于IL17A受体信号和
外围IL17A。重要的是,这伴随着1)PFC中神经元激活降低的灭绝 -
调节区域和2)小胶质细胞/T细胞/内皮器官(SFO),BBB-devoid
投射到PFC的区域。总的来说,这些观察结果为我们的假设提供了有关:严重哮喘相关的IL-
17a激活SFO中的复杂的多细胞信号传导级联
害怕。该假设将以3个目标进行检验。 AIM 1将确定IL-17A信号是否和Th17细胞活性是否
对于HDM-TH17/IL17A驱动的恐惧灭绝使IL-17A的能力不足
封锁(中和mAb)或Th17拮抗作用(小分子抑制剂)以逆转恐惧灭绝
Th2/Th17反应的小鼠的缺陷/神经免疫性改变,或重组IL17A以诱发恐惧
将评估具有TH2反应的小鼠的灭绝缺陷/神经免疫性改变。 AIM 2将确定
如果SFO?IL预测对于HDM-Th17/IL17A驱动的恐惧灭绝赤字是必要的和足够的
使用逆转录依赖性的化学遗传策略,我们将抑制或激活SFO?IL投影以评估
对用TH2与TH2/TH17A AIM 3治疗的HDM治疗小鼠恐惧灭绝的影响将识别转录组
与HDM-TH2/TH17相关的SFO和PFC中的轮廓,并使用单细胞RNASEQ恐惧,
SFO和PFC衍生细胞的转录曲线将使用免疫的细胞特异性特征产生
细胞,神经胶质,内皮细胞和神经元,以识别在HDM中唯一激活的DEG和信号通路
th2 vs th2/th17小鼠。验证和与HDM-TH2/TH17对恐惧的影响将使用
AIM 1/AIM 2组织。影响:我们的数据揭示了一种独特的核心机制
与慢性肺炎症有关,调节与心理健康有关的皮质缺陷和恐惧。
这些研究的完成将扩大我们对外围炎症介体如何调节的理解
大脑功能和行为,并确定与恐惧相关病理的新型风险因素和治疗靶标。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Ian Paul Lewkowich其他文献
Ian Paul Lewkowich的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Ian Paul Lewkowich', 18)}}的其他基金
Airway inflammation and fear: neuroimmune mechanisms and forebrain circuits
气道炎症和恐惧:神经免疫机制和前脑回路
- 批准号:
10677767 - 财政年份:2022
- 资助金额:
$ 35.09万 - 项目类别:
Preconceptual paternal allergen exposure, offspring asthma, and pulmonary gamma/delta T cell function
孕前父亲过敏原暴露、后代哮喘和肺 γ/δ T 细胞功能
- 批准号:
10300217 - 财政年份:2021
- 资助金额:
$ 35.09万 - 项目类别:
Preconceptual paternal allergen exposure, offspring asthma, and pulmonary gamma/delta T cell function
孕前父亲过敏原暴露、后代哮喘和肺 γ/δ T 细胞功能
- 批准号:
10427457 - 财政年份:2021
- 资助金额:
$ 35.09万 - 项目类别:
Perinatal Dysbiosis, Lung Development and Asthma
围产期生态失调、肺部发育和哮喘
- 批准号:
10187646 - 财政年份:2020
- 资助金额:
$ 35.09万 - 项目类别:
Perinatal Dysbiosis, Lung Development and Asthma
围产期生态失调、肺部发育和哮喘
- 批准号:
10405015 - 财政年份:2020
- 资助金额:
$ 35.09万 - 项目类别:
Perinatal Dysbiosis, Lung Development and Asthma
围产期生态失调、肺部发育和哮喘
- 批准号:
10625311 - 财政年份:2020
- 资助金额:
$ 35.09万 - 项目类别:
Preconceptual paternal environmental allergen exposure, sperm epigenetics and offspring asthma development
孕前父亲环境过敏原暴露、精子表观遗传学和后代哮喘发展
- 批准号:
9980030 - 财政年份:2020
- 资助金额:
$ 35.09万 - 项目类别:
Impact of prenatal HDM exposure in severely asthmatic mothers on offspring asthma
严重哮喘母亲产前暴露于 HDM 对后代哮喘的影响
- 批准号:
9243430 - 财政年份:2016
- 资助金额:
$ 35.09万 - 项目类别:
Mechanisms of IL-17A-mediated enhancement of asthma severity
IL-17A 介导的哮喘严重程度增强的机制
- 批准号:
8670181 - 财政年份:2014
- 资助金额:
$ 35.09万 - 项目类别:
Mechanisms of IL-17A-mediated enhancement of asthma severity
IL-17A 介导的哮喘严重程度增强的机制
- 批准号:
8842705 - 财政年份:2014
- 资助金额:
$ 35.09万 - 项目类别:
相似国自然基金
PFKFB3介导的糖酵解通过诱导气道上皮细胞功能失调加重哮喘气道炎症和气道重塑的机制
- 批准号:82300041
- 批准年份:2023
- 资助金额:20 万元
- 项目类别:青年科学基金项目
NGF通过上调ASIC1a表达激活AMPK/FoxO3a信号通路促进气道上皮细胞自噬诱导支气管哮喘的机制研究
- 批准号:82360008
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
外泌体介导肥大细胞类糜蛋白酶调控哮喘气道平滑肌增殖和机制研究
- 批准号:82370033
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
CD207阳性树突状细胞在过敏性哮喘气道炎症中作用及机制研究
- 批准号:82370035
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
Neuropilin-1活化肺2型固有淋巴样细胞促进肺哮喘发生的机制研究
- 批准号:32300727
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Relationship Between Indoor Ultrafine Particle Exposure and Respiratory Morbidity, Inflammation, and Oxidative Stress in Children with Asthma
室内超细颗粒物暴露与哮喘儿童呼吸系统发病率、炎症和氧化应激之间的关系
- 批准号:
10470611 - 财政年份:2022
- 资助金额:
$ 35.09万 - 项目类别:
Airway inflammation and fear: neuroimmune mechanisms and forebrain circuits
气道炎症和恐惧:神经免疫机制和前脑回路
- 批准号:
10677767 - 财政年份:2022
- 资助金额:
$ 35.09万 - 项目类别:
Effects of alcohol-induced dysregulation of lung hyaluronic acid
酒精引起的肺透明质酸失调的影响
- 批准号:
10614953 - 财政年份:2021
- 资助金额:
$ 35.09万 - 项目类别:
Protective effects of amlexanox against atherosclerosis
氨来呫诺对动脉粥样硬化的保护作用
- 批准号:
10400158 - 财政年份:2021
- 资助金额:
$ 35.09万 - 项目类别:
Effects of alcohol-induced dysregulation of lung hyaluronic acid
酒精引起的肺透明质酸失调的影响
- 批准号:
10389703 - 财政年份:2021
- 资助金额:
$ 35.09万 - 项目类别: